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Group B Streptococcus (GBs) is the leading cause of meningitis in newborn infants. Bacterial cell 
surface appendages, known as pili, have been recently described in streptococcal pathogens, 
including  GBs.  The  pilus  tip  adhesin,  PilA,  contributes  to  GBs  adherence  to  blood-brain 
barrier (BBB) endothelium; however, the host receptor and the contribution of PilA in central 
nervous system (Cns) disease pathogenesis are unknown. Here we show that PilA binds 
collagen, which promotes GBs interaction with the α2β1 integrin resulting in activation of host 
chemokine expression and neutrophil recruitment during infection. mice infected with the   
PilA-deficient  mutant  exhibit  delayed  mortality,  a  decrease  in  neutrophil  infiltration  and   
bacterial Cns dissemination. We find that PilA-mediated virulence is dependent on neutrophil 
influx as neutrophil depletion results in a decrease in BBB permeability and GBs–BBB penetration. 
our results suggest that the bacterial pilus, specifically the PilA adhesin, has a dual role in 
immune activation and bacterial entry into the Cns. 
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B
acterial  meningitis,  a  serious  infection  of  the  central   
nervous system (CNS), is a major cause of death and dis-
ability worldwide. Streptococcus agalactiae (Group B Strepto­
coccus, GBS), a Gram-positive bacterial pathogen, is the leading 
cause of meningitis in human newborns, and increasingly associ-
ated with invasive disease in the elderly. Despite the introduction 
of intrapartum antibiotic prophylaxis in pregnant women to pre-
vent GBS transmission, mortality rates in neonates remain high   
(10%),  and  25–50%  of  surviving  infants  experience  permanent 
neurologic sequelae, including cerebral palsy, seizure activity, deaf-
ness  and/or  blindness1.  Brain  damage  following  GBS  meningitis 
likely results from the loss of blood-brain barrier (BBB) integrity due 
to toxicity of bacterial products and/or activation of host inflamma-
tory mediators that compromise BBB function2. The human BBB, 
which is mainly composed of a single layer of specialized human 
brain microvascular endothelial cells (hBMEC), serves as a critical 
barrier to protect the CNS against microbial invasion. It is postu-
lated that GBS interaction with hBMEC, is the primary step in the 
pathogenesis  of  meningitis,  whereon  a  combination  of  bacterial 
transcytosis, endothelial cell injury, and inflammatory mechanisms 
combine to disrupt the BBB3.
Cell  surface  organelles  called  pili  were  recently  discovered   
in GBS and other streptococcal pathogens4–6. Pili are flexible append-
ages on the bacterial surface that have been shown to participate   
in  essential  events  for  infection  establishment,  including  adhe-
sion to the host cells, DNA transfer and biofilm formation7. Pili in   
Gram-positive bacteria consist of a backbone formed by covalently 
linked  monomers  of  a  major  pilin  with  associated  minor  pilin   
proteins that have been shown to be essential for adhesion to a   
variety of host tissues8–10.
The genes encoding pili in GBS are located within two distinct 
loci, designated as pilus island 1 and 2 (PI-1 and PI-2), with two 
variants of PI-2: PI-2a and PI-2b11. The overall gene organization 
of the two islands is similar that consists of three genes that encode 
LPXTG motif-carrying proteins corresponding to the major pilus 
subunit (PilB), two ancillary proteins (PilA and PilC) along with 
two  genes  encoding  transpeptidase  enzymes  (sortases)  involved 
in pilus assembly12. All clinical isolates of GBS carry at least one 
of the two pilus islands13. We have demonstrated previously that 
GBS clinical isolate NCTC10/84 (serotype V) expresses pili and 
that the pilus adhesin, PilA, contributes to GBS adherence to brain 
endothelium8. However, the identity of the host cell receptor and 
the contribution of GBS pili to the pathogenesis of CNS disease are 
largely unknown.
In  this  study,  we  examine  the  global  gene  expression  profile   
of  brain  endothelium  to  infection  with  a  GBS  isogenic  ∆pilA  
mutant  using  microarray,  real-time  PCR  with  reverse  transcrip-
tion  (RT–PCR),  and  protein  analysis.  Our  studies  suggest  that 
BBB endothelium responds to the GBS PilA with functional gene 
expression to promote the characteristic neutrophilic inflammatory 
response of acute bacterial meningitis. We also demonstrate that 
PilA interacts directly with collagen to engage integrins and integrin 
signalling  machinery,  which  contributes  to  the  pathogenesis  of   
meningitis in vivo.
a b
25 1,000
800
600
400
200
0
Media
GBS serotypes
I A III V
F
o
l
d
 
c
h
a
n
g
e
 
(
T
a
r
g
e
t
/
G
A
P
D
H
)
I
n
f
e
c
t
e
d
 
v
e
r
s
u
s
 
m
e
d
i
a
I
L
-
8
 
c
o
n
c
.
 
(
p
g
 
m
l
–
1
)
20
15
10
5
*** *** ***
***
***
***
**
**
0
IL-8
IL-6
CXCL1
CXCL2
CCL20
d e f
c
I A GST III V
Endotoxin
PilA-GST
F
o
l
d
 
c
h
a
n
g
e
 
(
I
L
-
8
/
G
A
P
D
H
)
T
r
e
a
t
e
d
 
v
e
r
s
u
s
 
m
e
d
i
a ***
***
***
25
20
15
10
5
0
Figure 1 | PilA promotes chemokine induction in brain endothelium. (a) Real-time RT–PCR analysis of chemokines IL-8, IL-6, CXCL1, CXCL2 and  
CCL20 in hBmEC 4 h post infection with WT GBs (black bars) or isogenic mutants ∆srr-1 (grey bars) and ∆pilA (white bars). Transcript levels were 
normalized to GAPDH and fold change was determined as described in methods; statistical analysis was performed with two-way AnoVA (Bonferroni 
test). (b) IL-8 secretion by hBmEC on infection with GBs WT strains (black bars) and isogenic ∆pilA mutants (white bars). Concentrations of IL-8 in 
hBmEC supernatants collected 4 h post infection were measured using ELIsA, two-way AnoVA (Bonferroni test); **P < 0.005; ***P < 0.001. (c) Transcript 
levels of IL-8 following treatment (4 h) with PilA–GsT fusion proteins from different GBs serotypes as well as control GsT protein (0.5 µm) and  
E. coli endotoxin (0.3 ng ml − 1). Cells were treated with the amount of endotoxin that were detected in PilA–GsT fusion proteins and GsT control protein 
preparations with a endotoxin detection kit, as described in methods; statistical analysis with one-way AnoVA (Tukey’s multiple comparison test).  
All experiments were performed three times in triplicate wells, and bars represent the standard deviation of the mean of one representative experiment, 
**P < 0.005; ***P < 0.001. (d–f) Binding of purified PilA–GsT protein to hBmEC. Cells were treated with PilA–GsT (d) or GsT (f) and then probed with 
either Anti-PilA antiserum or Anti-GsT Ab. nucleus is stained with DAPI. magnification of the boxed area in d is shown in e. scale bar, 20 µm.ARTICLE     
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Results
GBS PilA induces chemokine expression in brain endothelium. 
We have previously demonstrated that BBB endothelium has an 
active role in initiating a specific innate immune response to GBS 
infection,  promoting  neutrophil  activation  and  recruitment3,14.   
In  this  study,  global  transcriptional  analysis  of  hBMEC  during 
infection  with  a  GBS  PilA-deficient  mutant  revealed  a  marked 
reduction in the expression of CXC family of neutrophil chemokines 
IL-8, CXCL-1, and CXCL-2, as well as CCL-20 and IL-6, compared 
to  infection  with  WT  GBS  (Supplementary  Table  S1).  These   
results were confirmed in independent experiments using real-time 
RT–PCR (Fig. 1a), further suggesting that the hBMEC transcrip-
tional response is influenced by a PilA-mediated interaction.
The  pilA  gene  encoded  in  PI-2a  and  is  highly  homologous 
between  GBS  strains  that  harbour  this  locus  (~89%  identity).   
To  investigate  the  role  of  PilA  proteins  in  other  GBS  serotypes   
commonly associated with GBS meningitis, we constructed pilA 
targeted  mutants  in  GBS  strains  NEM316  (serotype  III)  and 
515 (serotype 1a) (Supplementary Fig. S1a). No difference in the   
growth  kinetics  or  hemolytic  activity  was  observed  between 
the  respective  WT  and  ∆pilA  mutant  strains  (Supplementary   
Fig.  S1b,c).  Consistent  with  our  microarray  analysis,  infection 
with the PilA-deficient strains resulted in less IL-8 protein secre-
tion compared with the respective WT parental strains (Fig. 1b).   
Complementation of the ∆pilA mutant with the intact pilA gene 
restored hBMEC IL-8 secretion to that observed during infection 
with WT GBS (Supplementary Fig. S1d).
PilA  promotes  IL-8  secretion  and  neutrophil  chemotaxis.  We 
next sought to determine whether GBS PilA is sufficient to induce 
IL-8 using purified recombinant PilA. PilA proteins, from several 
serotype  strains,  were  expressed  as  amino-terminal  GST  tagged 
fusion proteins (Supplementary Fig. S2a). Following purification, all 
proteins, including the GST protein control, contained low endo-
toxin levels (3 EU ml − 1 or 0.3 ng ml − 1). Treatment of hBMEC with 
PilA–GST proteins resulted in a significant induction of IL-8 tran-
scription (Fig. 1c). We also observed direct PilA protein binding to 
hBMEC compared with that of the GST control protein (Fig. 1d–f). 
We further analysed neutrophil recruitment to the site of infection 
using a cutaneous in vivo neutrophil recruitment assay, as described 
previously15. Neutrophil enzyme myeloperoxidase (MPO), which 
serves as an effective indicator of neutrophil infiltration16, was signi-
ficantly lower after infection with the ∆pilA mutant compared with 
the  WT  strain  (Fig.  2a).  This  increased  neutrophil  recruitment   
was independent of the number of bacteria present in the tissue, 
as  similar  bacterial  colony-forming  units  (CFU)  were  recovered 
from  the  skin  for  both  the  WT  and  ∆pilA  mutant  under  these 
conditions (Fig. 2b). Similar results were observed when assessing 
polymorphornuclear (PMN) cell recruitment directly in the CNS.   
Mice injected intracranially with the ∆pilA mutant exhibited less 
PMN infiltrate compared with animals inoculated with WT GBS 
(Fig. 2c–h). Taken together, these results indicate that GBS PilA 
promotes  IL-8  secretion  and  functional  neutrophil  signalling   
pathways in vivo, resulting in neutrophil recruitment during active 
GBS infection.
Collagen promotes PilA–BBB interaction. Sequence analysis of 
GBS PilA as well as comparison to a recent crystal structure of a 
GBS PilA orthologue17 reveals several distinct domains including 
two Cna-B-like domains, which are similar to IgG domains found 
in S. aureus adhesins18, and an Integrin I-like domain that resembles 
the A3 domain of human von Willebrand factor, a molecule shown 
to interact with collagens19. Because a recent report demonstrated 
that the PilA von Willebrand factor region confers adherent proper-
ties to host cells20, we further hypothesized that this may include 
PilA-mediated binding to collagen. We first observed that binding   
to  immobilized  collagen  I  was  impaired  in  the  ∆pilA  mutant   
(Fig. 3a). Direct binding of purified PilA–GST protein to collagen I   
was also assessed in an enzyme-linked immunosorbent (ELISA)-
based assay where we observed a dose-dependent increase in the 
binding of the PilA protein, and not the GST control, to collagen   
(Fig. 3b). When GBS was incubated with increasing amounts of colla-
gen, we observed an increase in both bacterial attachment and inter-
nalization of WT GBS and not the ∆pilA mutant strain (Fig. 3c, d; 
 Supplementary Fig. S2b,c). Further, PilA-coated latex beads bound 
hBMEC more abundantly in the presence of collagen compared 
with BSA or GST-coated beads (Fig. 3e). These results suggest that 
collagen promotes PilA–hBMEC interaction.
Role  of  α2β1  integrin  and  FAK  signalling  in  BBB  activation. 
Extracellular matrix proteins like collagen typically interact with 
cell  surface  integrins  to  initiate  downstream  signalling  cascades 
mediated through Focal adhesion kinase (FAK), which is central to   
integrin-mediated  signalling21.  As  shown  in  Figure  4a,  confocal   
microscopy depicted co-localization of PilA–GST-coated latex beads   
with  FAK  at  the  focal  adhesion  sites.  This  led  us  to  investigate 
whether integrins, which are present in focal adhesion sites, might 
be acting as the host receptor for PilA. Cells generally express two 
c
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Figure 2 | PilA induces neutrophil chemotaxis. (a) In vivo neutrophil 
recruitment was assessed by measuring mPo activity in mice  
(CD1, male, n = 8 per group) skin homogenates 4 h post infection either 
with WT GBs (black squares) or ∆pilA mutant (red squares). mPo assays 
were performed on mice skin homogenates after subcutaneous injection 
with 1×106 CFu of either WT GBs or ∆pilA mutant strain. (b) Bacterial 
counts in skin homogenates were assessed by plating serial-fold dilutions 
on Todd-Hewitt broth agar plates. Experiments were performed twice,  
a representative experiment is shown. Bars represent mean mPo levels 
or bacterial cfu, statistical analaysis was performed using student’s t-test; 
**P < 0.005; ns, non-significant. (c–h) neutrophil recruitment in the Cns 
was assessed following direct intracranial injection in 5-day-old mice 
(n = 4 per group) 8–10 h post inoculation with WT GBs or ∆pilA mutant. 
Representative images of brains from two independent experiments are 
shown for two mice (c–e) infected with WT (same mouse in c,d) and 
two mice (f–h) infected with ∆pilA mutant (same mouse in f,g). Brain 
sections stained with hematoxylin and eosin (H&E) (c,f) depict meningeal 
thickening during WT infection (c, arrows) and Pmn infiltration by 
immunohistochemical detection with FITC–anti-Ly6G Ab (d,e,g,h).  
scale bar, 20 µm.ARTICLE
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predominantly collagen binding integrins: α1β1 and α2β1 (ref. 22).   
Previous  integrin  profiling  studies  revealed  that  hBMEC  only   
express α2 and β1 integrins23. When α2β1 or β1 integrins were blocked 
using  respective  function-blocking  monoclonal  antibodies,  we 
observed a significant reduction in WT GBS attachment and inva-
sion in hBMEC compared with an isotype control antibody (Fig. 4b;   
Supplementary  Fig.  S3a,b).  There  was  no  noteworthy  change  in 
the adherence and invasive capabilities of the ∆pilA mutant strain, 
indicating that α2β1 integrins are required for PilA-mediated GBS 
penetration of BBB endothelium. Interestingly, IL-8 secretion by 
hBMEC on infection with WT GBS was also significantly reduced   
in presence of both α2β1 or β1 integrin function-blocking mono-
clonal antibodies (Fig. 4c; Supplementary Fig. S3c). Furthermore, 
as described in the Methods, we knocked down the expression of β1 
integrin in hBMEC by short hairpin RNA (Supplementary Fig. S3d). 
Bacterial invasion, as well as IL-8 secretion on infection with WT 
GBS, was significantly reduced in β1 integrin knockdown hBMEC 
cells  compared  with  cells  transfected  with  the  scramble  shRNA 
control (Fig. 4d,e). Finally, we observed a significant reduction in 
PilA–GST binding to β1 integrin knockdown hBMEC cells, as well 
as in cells treated with anti-α2β1 monoclonal Ab, as compared with 
cells transfected with the scramble shRNA control (Supplementary 
Fig. S3e–g). These results further suggest that integrin α2β1 acts as   
a receptor for GBS PilA.
The non-receptor FAK localizes with β1 integrins and becomes 
activated  in  response  to  integrin  initiated  signalling  processes21. 
Previously, phosphorylation of FAK was shown to be crucial for 
invasion of hBMEC by a GBS serotype III strain24. We similarly 
show  that  FAK,  as  well  as  Akt  and  Erk1/2,  are  phosphorylated   
during  WT  GBS  infection,  whereas  little-to-no  phosphorylation 
was observed during infection with the ∆pilA mutant over the same 
time period (Fig. 5a). To further examine the impact of FAK on 
PilA-mediated cellular invasion and IL-8 secretion, hBMECs were 
transfected with the carboxy-terminally truncated FAK-derivative 
FRNK (FAK-related non-kinase), which does not contain an active 
kinase domain, and acts as a dominant negative form when over-
expressed in hBMEC (FRNK/hBMEC)25. We did not observe any 
change in bacterial adherence between different cell lines during 
infection with either WT GBS or ∆pilA mutant (Fig 5b). However, 
we did observe a reduction in cellular invasion and IL-8 secretion 
during WT GBS infection of FRNK/hBMEC cells compared with 
the WT FAK control (Fig. 5c,d). To examine whether bacterial inva-
sion itself is required for PilA-mediated IL-8 secretion, we used 
cytochalasin D to block actin polymerization in hBMEC during 
GBS  infection.  This  treatment  inhibited  bacterial  internalization   
in a dose-dependent manner, but did not lead to a reduction in   
bacterial adherence or PilA-mediated IL-8 secretion (Supplementary 
Fig. S4). Taken together, these results confirm that GBS invasion   
of brain endothelium is not a prerequisite for IL-8 secretion and 
imply that PilA mediated engagement of α2β1 integrins initiates 
FAK signalling events that lead to both chemokine secretion and 
bacterial penetration.
We  further  investigated  the  role  of  phosphatidylinositol-3 
kinase (PI3K) as well as the MAP kinase Erk1/2 pathway, both of 
which signal downstream of FAK, during PilA-mediated immune 
activation and cellular invasion. Inhibition of PI3K activity with 
LY294002 resulted in a significant reduction in bacterial invasion 
without affecting IL-8 secretion (Fig. 5e,f). In contrast, treatment 
of cells with Erk1/2 pathway inhibitor U0126, resulted in a drastic 
decline in IL-8 release (85%) without perturbing the cellular inva-
sion process (Fig. 5g,h). We also analysed the effect of these inhibi-
tors  on  chemokine  secretion  and  neutrophil  chemotaxis  in  vivo  
by  measuring  KC  (functional  murine  homologue  of  IL-8)  and   
MPO levels as described above. Significantly lower levels of KC   
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and subsequent neutrophil recruitment were observed at the site 
of WT GBS infection with prior treatment of U0126 (Fig. 5i,j).   
No  significant  difference  was  observed  when  similar  treatment   
was  carried  out  with  the  PI3 K  inhibitor  LY294002  or  during   
infection  with  ∆pilA  mutant.  Overall,  these  studies  suggest  that   
PilA  mediated  bacterial  invasion  and  induction  of  chemokine   
signalling pathways diverge downstream of FAK in possibly inde-
pendent pathways.
PilA contributes to pathogenesis of meningitis in vivo. To exam-
ine the contribution of PilA to the pathogenesis of GBS CNS infec-
tion in vivo, we employed our mouse model of GBS hematogenous 
meningitis, as described previously3,26. Mice (8-week, CD-1 male) 
were intravenously injected with either WT GBS or ∆pilA mutant. 
All the WT GBS-infected mice died after 54 h whereas it took 148 h   
for all the ∆pilA mutant-infected mice to succumb to infection. The 
median survival time of the WT GBS-infected mice was signifi-
cantly lower compared with ∆pilA mutant-infected mice (P = 0.036, 
Log Rank test) (Fig. 6a). In a similar separate experiment, mice 
infected with WT GBS or the ∆pilA mutant, were killed after 24 h 
to assess bacterial dissemination to the brain. The levels of GBS 
detected in the blood or spleen of each group of mice were essen-
tially identical whereas the bacterial brain load in ∆pilA-infected 
mice  was  significantly  lower  than  in  mice  infected  with  WT   
(Fig. 6b). Also the CFU recovered from the brain versus the blood-
stream was significantly greater in the mice infected with WT com-
pared with the ∆pilA mutant (Fig. 6c). RT–PCR analysis revealed 
that  the  mice  infected  with  ∆pilA  mutant  exhibited  decreased   
brain transcript levels of KC, compared with mice infected with WT 
GBS (Fig. 6d). Histopathological analysis of the brain tissue sec-
tions from all the animals infected with WT GBS exhibited classical   
features  of  meningitis  such  as  meningeal  thickening;  massive   
influx of inflammatory cells, especially neutrophils; and substantial 
haemorrhaging that were rare or absent in animals infected with 
∆pilA mutant strain (Supplementary Fig. S5). Images from repre-
sentative mice infected with WT and the ∆pilA mutant, or following 
PBS injection, are shown in Figure 6e–j. Presence of WT GBS was 
visualized in meninges by immunohistochemical analysis, whereas 
the PilA deficient strain was rarely observed (Fig. 6k–n). In a sepa-
rate experiment, we assessed bacterial load and chemokine expres-
sion in multiple tissues, as well as brain pathology during infection 
with the WT and ∆pilA mutant over time. In general, at all time 
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points tested, even at time of death, mice infected with the ∆pilA 
mutant had substantially less inflammatory infiltrate and necrotic 
injury in the brain than those infected with WT GBS (Supplementary   
Fig. S6). Consistent with our previous experiments, significantly 
more bacterial CFU and KC expression was observed in the brain 
and  lungs  of  mice  infected  with  the  WT  strain  (Supplementary   
Fig. S7). Similar results were obtained in vitro using cervical (HeLa) 
and lung (A549) epithelial cell lines (Supplementary Fig. S8) demon-
strating that PilA contributes to both adherence and chemokine 
induction in these different cell types.
Role of neutrophils during GBS meningitis. Our observation that 
WT GBS-infected mice had a higher level of chemokine KC as well 
as significant infiltration of leukocytes, especially neutrophils, led 
us to investigate the contribution of neutrophils to BBB permea-
bility and the progression of GBS meningitis. Mice were rendered 
neutropenic using monoclonal antibody RB6–8C5 (ref. 27) before 
intravenous (i.v.) infection with GBS; we observed sustained neutro-
penia during the course of our experiment (Supplementary Fig. S9).   
Approximately 45% of the RB6–8C5-treated animals succumbed 
to death within the first 24 h of infection, probably due to septic 
shock. This was evidenced by drop in body temperature, higher bac-
terial load in the blood and lungs, and higher levels of sepsis-related 
cytokines (IL-1β and IL-6) in serum, spleen and lung in neutro-
penic mice compared with those treated with isotype control Ab 
(Supplementary Fig. S10a–h). Interestingly, the RB6–8C5-treated 
mice that survived the initial sepsis lived longer and also exhibited 
lower bacterial counts in the brain compared with control mice 
(Fig. 7a–c). Following survival of sepsis, the median survival time 
of neutropenic mice was higher compared with control Ab-treated 
mice (61 versus 46 h). These results suggest that neutropenia may be 
conferring a survival advantage during GBS CNS disease. We next 
sought to examine the permeability of brain endothelium by Evans 
blue (EB) dye extravasation28. Mice were either treated with PBS, 
RB6–8C5 or isotype control Ab followed by i.v. injection of PBS   
(for PBS-treated mice) or WT GBS (for Ab-treated mice). Mice   
were killed 24 h post infection following an i.v. injection with EB 
(100 µl,  2%,  w/v).  Brains  recovered  from  mice  treated  with  the 
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isotype control Ab were visibly more blue compared with either 
RB6–8C5 or PBS-treated non-infected mice (Fig. 7d). Significantly 
higher EB leaching into the brain was quantified in mice treated 
with control Ab compared with neutropenic mice or PBS-treated 
mice (Fig. 7e). Bacterial load in the brain as well as BBB perme-
ability  measured  by  EB  extravasation  24 h  post  infection  with   
the ∆pilA mutant was similar in mice treated with both the neutro-
phil depleting and isotype control Ab (Supplementary Fig. S10i,j). 
In a separate experiment, we also assessed BBB permeability using 
FITC-albumin as a tracer29. We similarly observed a generalized 
leakage  from  blood  vessels  within  the  brain  parenchyma  dur-
ing GBS infection in mice that were treated with isotype control   
Ab  compared  with  animals  treated  with  RB6–8C5  Ab  or  PBS   
alone (Fig. 7f–i).
Discussion
The pathogenesis of GBS meningitis involves haematogenous spread 
and entry into the CNS by invading the BBB; however, the precise 
mechanism(s) whereby the bacterium leaves the bloodstream and 
gains access to the CNS is still being elucidated. In this study, we 
report that the pilus tip protein, PilA, which mediates GBS attach-
ment to the brain endothelium, contributes to virulence by pro-
moting characteristic neutrophilic infiltrate during acute bacterial 
meningitis. We further demonstrate that PilA binds the extracel-
lular matrix component collagen, which then engages α2β1 integrins 
on brain endothelium to dually promote bacterial attachment and 
proinflammatory chemokine release. Increased neutrophilic infil-
trate was correlated with increased BBB permeability and higher 
levels of bacterial CNS penetration in vivo (Fig. 8). Thus, it is likely 
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that the PilA–BBB interaction represents one of the early molecular 
events that contribute to disease progression resulting in a detri-
mental outcome for the host.
The BBB that is primarily composed of a specialized layer of 
brain microvascular endothelial cells separates the brain and its sur-
rounding tissues maintaining the proper biochemical conditions for 
normal brain function30. Interaction of bacterial components with 
the BBB is the central event in the pathogenesis of BBB penetration 
and a prerequisite for development of severe meningeal inflamma-
tion, the hallmark of meningitis. GBS factors shown to promote an 
interaction of the bacterium with brain endothelium include lipo-
tecichoic  acid31,  β-hemolysin/cytolysin  (β-h/c)3,  pili8,  serine-rich 
repeat glycoprotein (Srr-1)26, fibrinogen-binding protein32, laminin-
binding protein33 and recently a hypervirulent GBS adhesin34. The 
majority of these cell surface associated factors directly promote 
attachment  and/or  invasion  of  GBS  in  different  host  cell  types 
including hBMEC. We have shown previously that a GBS mutant 
lacking anchored lipotecichoic acid induced similar levels of IL-8 
expression during hBMEC infection as compared with the WT GBS 
strain31. Here we similarly demonstrate that GBS surface adhesin/
invasin Srr-1 does not contribute to cytokine/chemokine induction 
(Supplementary Table S1), suggesting that a reduction in bacterial 
adherence/invasion is not solely responsible for general decreases in 
gene transcription observed during infection.
We have previously demonstrated that GBS infection of hBMEC 
results in the upregulation of proinflammatory cytokines and chem-
okines functioning to orchestrate neutrophil recruitment and activa-
tion, and that this effect was largely due to the major cell associated 
virulence factor β-h/c3,14. Compared with WT GBS, infection with 
a PilA-deficient mutant resulted in significantly less gene induction 
and secretion of key neutrophil CXC chemokines as well as func-
tional neutrophil chemotaxis to the site of infection. We speculate 
that as pili are long filamentous organelles protruding away from 
the bacterial surface, pili-mediated contact may represent a crucial 
first step in GBS–BBB engagement, after which other virulence fac-
tors such as the β-h/c toxin will probably contribute to disease pro-
gression. Our results that a GBS pilin component contributes to the 
host proinflammatory response are consistent with recent studies 
on other piliated pathogens. It was observed that piliated strains of 
pneumococcus evoked a higher TNFα response than non-piliated 
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strains during systemic infection5. Similarly, type I pili (P pili) of 
uropathogenic Escherichia coli have been shown to stimulate IL-8 
release in the urinary tract mucosa35.
PilA-mediated binding of collagen enhanced GBS attachment 
as well as uptake into hBMEC in a dose-dependent manner. Our 
results are consistent with other studies showing that RrgA, the 
pneumococcal homologue of GBS PilA, binds to various ECM pro-
teins including the collagen36, and that minor pilin protein Cpa of 
Group A Streptococcus (GAS) possess collagen-binding capabili-
ties37. The high sequence similarity between RrgA and pilus adhes-
ins from GAS and GBS (identity level of ~50% with similarity levels 
beyond 70%) points to the possibility that the three-dimensional 
fold of these proteins could be highly similar, suggesting that pili 
components may contribute to a general mechanism of pathogen 
entry and inflammatory induction.
Many pathogenic bacteria exploit integrin-mediated signalling 
for entry into the host cells38,39. Here we demonstrate that the inter-
action between PilA and α2β1 integrin in BBB endothelium prob-
ably results in FAK activation to initiate signalling pathways lead-
ing to both bacterial internalization and proinflammatory cytokine 
release,  which  results  in  functional  neutrophil  chemotaxis  and 
disease progression. There are only a few reports that suggest other 
bacterial pathogens elaborate factors that employ similar strategies. 
These include the oral streptococcal protein I/IIf that interacts with 
α5β1 integrins40, and the YadA invasin of Yersinia pseudotuberculo­
sis and the outer membrane protein, Opc of Nesseria meningitidis, 
both of which bind fibronectin to anchor to β1 integrins resulting   
in bacterial uptake as well as IL-8 secretion41–43.
Given  that  integrins  preferentially  localize  to  the  basolateral   
surface  of  polarized  endothelium44,  we  propose  that  these  early 
molecular  interactions  of  GBS  with  the  BBB  may  alter  cellular 
polarity as has been described for Helicobacter pylori45. It has also 
been demonstrated that GBS is capable of paracellular transit across 
an  epithelial  cell  barrier  where  the  bacterium  co-localized  with 
junctional  protein  complexes46.  Whether  these  interactions  act 
to disrupt tight junctional proteins and result in a non-polarized   
distribution of proteins on the BBB plasma membrane remains to 
be investigated.
Our in vitro results were corroborated in vivo in a murine model 
of GBS haematogenous meningitis. Infection with the PilA-deficient 
mutant strain resulted in delayed mortality, decreased neutrophil 
infiltration and bacterial CNS dissemination and less expression of 
murine CXC chemokine KC. Histopathological analysis of the mice 
brains infected with WT GBS exhibited classical features of menin-
gitis, such as thickening of the meninges, massive influx of inflam-
matory cells, specially neutrophils, and brain tissue damage. Also 
during the course of disease progression, significant differences in 
the bacterial load and KC levels between WT and ∆pilA mutant-
infected animals were observed only in tissues that are typical sites 
of GBS infection such as brain and lung, whereas no difference was 
observed in other tissues including liver, kidney and spleen (Supple-
mentary Fig. S7). Thus, it is likely that other factors contribute to 
GBS CNS tropism. PilA-mediated virulence was also found to be 
dependent  on  neutrophil  influx.  Our  results  suggest  that  deple-
tion of peripheral neutrophils conferred a survival benefit at later 
time points in GBS infection. Neutropenia was also accompanied 
by a decreased bacterial brain load and BBB permeability during 
infection. While some studies have demonstrated that the depletion 
of neutrophils was detrimental to the host during bacterial infec-
tion47–50, others have observed that PMN depletion prolonged host 
survival after infection51–53. Our findings demonstrate an association 
between leuckocyte trafficking and BBB permeability and increased 
GBS  penetration  of  the  CNS,  suggesting  that  PMN-mediated   
damage of the BBB has a significant role in the pathogenesis of   
GBS meningitis.
Overall, our findings suggest that GBS pili hijack host integrin 
machinery for inflammatory activation of brain endothelium and 
subsequent bacterial CNS entry. The resulting localized inflamma-
tion initiated by these early molecular events results in increased 
permeability of the BBB and facilitates bacterial passage from the 
blood stream to the immune privileged site of the CNS. To the best 
of our knowledge, this is the first report that describes the mecha-
nistic and dual role of pili during CNS disease pathogenesis, as well 
the deleterious role of neutrophil infiltrate during GBS meningitis. 
Although  currently  there  is  no  vaccine  available  for  GBS  infec-
tion, recent reports have identified GBS pili components, and PilA 
in particular as it is highly conserved between strains, as potential 
vaccine candidates54. Thus, our studies provide further mechanis-
tic insight into the contribution of pili components to GBS disease 
pathogenesis.
Methods
Bacterial strains. Streptococcus agalactiae (GBS) serotype V strain NCTC 10/84 
and its isogenic ∆pilA mutant that was created by in-frame allelic replacement with 
a chloramphenicol resistance cassette8 were primarily used for the experiments. 
Mutations in the pilA gene in other GBS serotypes (serotype IA strain 515 and 
serotype III strain NEM316) were created by insertional duplication mutagenesis. 
Briefly, part of the pilA gene was amplified by PCR using the following set of  
primers; PilA(F): GTTTGTCGCAAATACCGCTTA and PilA(R): CATTACTCTC 
AACCTTAACTTG and cloned in pHY304. After transformation with respective 
recombinant plasmids insertional mutants were selected on Erythromycin selective 
plates. pilA gene deletion was confirmed by western blotting whole bacterial lysates 
using anti-PilA Ab. For complementation studies, full length pilA gene was ampli-
fied using the following sets of primers, KpnI–PilA(F): 5′-AGTCGGTACCATGAG 
AAAATA-3′; BglII–PilA(R): 5′-ATCGAGATCTTTAATCTTTTTC-3′ and cloned 
in pDCErm. ∆pilA mutant strain was transformed with the recombinant plasmid 
for generation of complemented strain. WT, ∆pilA mutants and complemented 
GBS strains were grown in Todd-Hewitt broth THB at 37 °C. Erythromycin  
at a concentration of 5 µg ml − 1 was incorporated in the growth medium when 
required.
Cell lines and infection assays. The human brain microvascular endothelial 
cell line was kindly provided by Kwang Sik Kim (Johns Hopkins University) and 
cultured in RPMI1640 containing 10% FBS, 10% Nuserum and 1% nonessential 
amino acids3,31. hBMECs stably expressing shRNA targeting β1 integrin (hBMEC 
∆β1) or cells expressing a control shRNA were generated by transfection  
(Santa Cruz Biotechnology). Knockdown of integrin β1 was verified using standard 
flow cytometry assay (FACS; BD Biosciences). FAK–WT/hBMEC and FRNK/
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Figure 8 | Model of GBS PilA-mediated CNS infection. (1) PilA binds the 
extracellular matrix component collagen, which then engages α2β1 integrins 
on brain endothelium. (2) This leads to FAK activation and subsequent 
intracellular signalling. (3) signalling pathway involving PI3K results in 
actin rearrangement and bacterial uptake. (4) A parallel signalling pathway 
involving mEK1/2 and Erk1/2 activation leads to IL-8 secretion. (5) This 
further results in functional neutrophil chemotaxis and activation. (6) 
Increased neutrophilic infiltrate damages the BBB resulting in increased 
BBB permeability, which likely facilitates further bacterial passage from the 
blood stream to the Cns.ARTICLE
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hBMEC cells are grown as reported25. Infection assays for microarray analysis, 
cytokine secretion, bacterial adherence and invasion were previously described3,31. 
Bacterial adherence and invasion was calculated as (recovered CFU/initial  
inoculum CFU)×100%. For inhibition studies, cells were pretreated for 30 min  
with indicated amounts of cytochalasin D, LY294002 and U0126, or 10 µg ml − 1 of 
anti-integrin β1 or anti-α2β1 integrin Ab before incubation with bacteria.
RT–PCR and ELISA. RNA isolation, cDNA preparation and quantitative PCR 
was performed according to standard protocols. Primer sequences for IL-6, IL-8, 
CXCL1, CXCL2, CCL20, KC and β-actin and primer efficiencies are reported  
earlier15,55. Relative gene expression was calculated using the following equation: 
Relative gene expression = target gene efficiency  × (CT control − CT sample)/
efficiency for β-actin or GAPDH × (CT control − CT sample). Concentrations of 
IL-8, KC (R&D systems) or IL-1β and IL-6 (eBiosciences) in hBMEC supernatants 
or in mice tissue homogenates were determined by ELISA.
Microarray analysis. Microarray experiments were performed using Sentrix 
Human-8 Expression BeadChips (Illumina). Data were analysed using a statistical 
algorithm developed for high-density oligonucleotide arrays56. The microarray data 
has been deposited in the EMBL-EBI under accession code E-MTAB-765.
PilA–GST purification and generation of antiserum. pilA gene from the genomic 
DNA of different GBS strains (serotype IA, III and V) was amplified using the  
following primers, SalI-PilA-F (5′-ATGCAGGTCGACAAGTACCGTACCGGA 
AAAT-3′), NotI-PilA-R (5′-ATGCAGCGGCCGCTTATCCTTTTGGTGGAAT 
AT-3′) and cloned in pGEX4T-2 (GE HealthSciences). E. coli BL21(DE3) cells 
carrying pGEX–PilA were grown at 25 °C and protein expression was induced with 
1 mM IPTG for 8 h. GST–PilA proteins were purified from the crude extracts using 
Glutathione–Sepharose (GE Healthsciences) column chromatography. Fractions 
collected were concentrated using Amicon Ultra centrifugal devices (Millipore) and 
buffer exchanged in PBS using PD10 columns (GE Healthsciences). Similarly puri-
fied GST served as a control protein. The proteins were made endotoxin-free using 
ToxinEraser Endotoxin Removal Kit (Genscript) and amount of endotoxin was 
quantitated using ToxinSensor Chromogenic LAL Endotoxin Assay Kit (Genscript). 
Anti-serum against PilA was generated by immunizing New Zealand white rabbits 
with PilA–(His)6 protein preparation mixed with Freund’s complete adjuvant  
(Pacific Immunology). The specificity of the anti-serum was determined by ELISA.
Inhibitors and antibodies. Following antibodies and inhibitors were used: rabbit 
anti-FAK, monoclonal anti-integrin β1 and monoclonal anti-α2β1 integrin (Mil-
lipore); monoclonal anti-GBS (Acris); monoclonal anti-FAK, FITC rat anti-mouse 
Ly6G and FITC rat IgG2a (BD Biosciences); anti-GST and goat polyclonal anti-Akt 
(Santa Cruz Biotechnology); monoclonal anti-FITC biotin conjugate and anti-lam-
inin (Sigma); Alexa fluor 647 anti-mouse CD45 (BioLegend); anti-phospho p44/42 
MAPK (pY204) and p44/42 MAPK rabbit Ab (Cell Signaling); rabbit polyclonal anti-
phospho FAK (pY397) and rabbit polyclonal anti-phospho Akt (pS473) (Invitrogen); 
cytochalasin D, LY294002 (PI3K inhibitor), and U0126 (MEK1/2 inhibitor) (Sigma).
Bacteria and PilA binding to collagen. Bacterial binding to collagen was  
determined by crystal violet staining57. Stain bound to bacteria was released by  
addition of 20 mM citrate buffer, pH 4.3, and absorbance was measured at 595 nm.
Binding of PilA–GST or GST to collagen was determined by ELISA36.  
ELISA plates coated with collagen I or BSA (2 µg per well) were treated with  
different concentration. of either PilA–GST or GST protein. After subsequent 
incubation with anti-PilA or anti-GST Ab and HRP-conjugated secondary Abs, 
chromophore was developed using 3,3′-, 5,5′-tetramethylbenzidine (Sigma) and 
the absorbance was measured at 450 nm.
Cellular attachment of protein-coated latex beads. Latex beads (1.1 µm in 
diameter, Sigma) were coated with PilA–GST or GST58 proteins (1 mg ml − 1) in 
coupling buffer (50 mM MES pH 6.1, 200 mM NaCl) at 4 °C for overnight. After 
washing, nonspecific sites were blocked with either 2% BSA or collagen. hBMEC 
monolayer was incubated with protein-coated latex beads at an approximate cell:
bead ratio of 1:10 for 4 h.
Confocal microscopy. hBMECs treated with PilA protein or PilA-coated beads 
were fixed with 4% PFA and permeabilized with 0.1% triton X-100. PilA was 
stained with anti-PilA (1:1,000) Ab and Alexa Fluor 488 conjugated goat anti- 
rabbit Ab (Invitrogen). FAK was stained with anti-FAK Ab (1:1,000) followed  
by Cy5 conjugated rabbit anti-mouse Ab (Invitrogen). DNA was stained with 
To-Pro-3 iodide (Invitrogen). Coverslips were mounted on glass slides using 
Vectashiled (Vector labs) and visualized with a confocal laser scanning microscope 
(Leica Microsystems).
Western blotting. hBMEC were infected with WT GBS and ∆pilA mutant for 
different time points and lysed using RIPA buffer (Thermo Scientific) containing 
2 mM Na3VO4, 100 mM NaF, 10 mM sodium pyrophosphate, 1 mM PMSF and 
protease inhibitor cocktail (Calbiochem). Cell lysates (40 µg) were probed with 
antibodies against phosphorylated and non-phosphorylated forms of FAK, Akt and 
Erk1/2 (all Abs at 1:1,000).
In vivo neutrophil chemotaxis. All animal experiments were approved by the 
Committee on the use and care of animals at San Diego State University (SDSU) 
protocol APF 10-08-024D and performed using accepted veterinary standards. 
Neutrophil recruitment was determined using a cutaneous in vivo neutrophil 
chemotaxis assay15,55. For determining signalling pathways resulting in neutrophil 
chemotaxis, 2 h before bacterial injection mice were injected subcutaneously with 
1 mg kg − 1 of U0126, LY294002 or DMSO. To assess PMN recruitment directly in 
the CNS, 5-day-old pups (C57BL/6, n = 4 per group) were infected intracranially59 
with 1–3×105 CFU (25 µl) of either WT GBS or ∆pilA mutant. Following sacrifice, 
8–10 h post infection, paraffin embedded brain sections were immunostained 
with FITC rat anti-mouse Ly6G (1:50) or stained with hematoxylin and eosin 
(H&E).
Mouse model of haematogenous meningitis. 8-week-old male CD-1 mice were 
injected intravenously with 6–7×107 CFU of WT GBS or isogenic ∆pilA mutant. 
At different time points after injection (24, 48 and 72 h), mice were euthanized and 
blood, brain and various other tissues such as lungs, spleen, liver and kidney were 
collected. One half of brain was fixed in 4% PFA for histopathological analysis. Of 
remaining brain tissue, ~30 mg was processed for RNA extraction. The remaining 
brain tissues as well as other tissues were homogenized in PBS and the homo-
genates were either plated on THA plates for enumeration of bacterial colonies or 
used for quantitation of chemokine KC by ELISA.
Peripheral polymorphoneutrophil depletion. PMN depletion was induced  
by the intraperitoneal administration of 50 µg of RB6–8C5 monoclonal Ab (BD Bio-
sciences) to 6–8 weeks old CD-1 male mice 24 h before bacterial injection. Control 
mice received equivalent amount of isotype control Ab, rat IgG2b. The extent of PMN 
depletion was determined by staining total blood leukocytes with with Alexa Fluor 
647-labelled anti-CD45 and FITC-labelled anti-Ly6G antibodies (both at 1:500) and 
performing FACS at 24 and 48 h following injection of RB6–8C5 or IgG2b.
BBB permeability measurement. BBB permeability was determined by  
EB vascular permeability as well as by leakage of FITC-albumin28,29. 1 h before 
ethuanization, 100 µl of 2% EB was injected i.v.. After sacrifice, mice brains were 
homogenized in PBS, proteins were precipitated by 60% trichloroacetic acid, and 
concentration of EB in the supernatants was determined by measuring absorbance 
at 610 nm. EB dye permeability is expressed as µg of EB per g of brain tissue against 
a standard curve. Alternatively, 30 min before sacrifice, mice were i.v. injected  
with 10 ml kg − 1 of FITC-albumin, and brains were subsequently analysed by  
immunohistochemistry.
Immunohistochemistry. GBS was detected in brain sections by staining with  
anti-GBS Ab (1:20) and visualized using the Mouse on Mouse kit (Vector labs) 
containing a biotinylated anti-mouse IgG in conjunction with streptavidin-HRP. 
GBS was also detected by staining brain sections with anti-mouse secondary Ab 
conjugated to AlexaFluor 488. Blood vessels were labelled with Anti-laminin 
(1:50), nuclei with To-Pro, and the samples were viewed on a confocal microscope. 
Extravasation of FITC–albumin in the brains of mice was detected using an anti-
FITC biotin conjugate (1:400) and visualized by streptavidin conjugated to Alexa 
Fluor 488.
Statistical analysis. Graphpad Prism version 4.03 was used for statistical analysis. 
Statistical significance was accepted at P < 0.05. 
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